2025 will be remembered as the year Brazilian music stopped asking for permission and simply took over. Sertanejo tracks ...

The first pills are expected to hit the market next month and attract people who don’t want to give themselves shots.

Stock rose again on Tuesday following the release of third-quarter gross domestic product that revealed the U.S. economy grew faster than expected in the period. The S&P 500 closed at a record.

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy, the first daily oral medication for obesity treatment. The once-daily tablet — ...

U.S. regulators approved the first GLP-1 weight-loss pill—a tablet formulation of Novo Nordisk’s NOVO.B-0.40%decrease; red down pointing triangle Ozempic and Wegovy—ushering in a new era of the ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo Nordisk, the pill is taken once a day. The company’s original version of ...

FDA approves Novo Nordisk's weight-loss pill Novo aims to regain market share from Eli Lilly Pill broadens potential patient pool The pill is 25 milligrams of semaglutide, the same active ingredient ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at ...

Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it picked up a year ago, was hit with a warning letter from the FDA last month. The ...

This is read by an automated voice. Please report any issues or inconsistencies here. Carl Carlton, the funk and R&B singer known for upbeat, era-embodying singles like “Everlasting Love” and “She’s a ...

As both Novo Nordisk and Eli Lilly race to develop their long-anticipated oral GLP-1 obesity meds, a new report shows one taking a clear lead among potential prescribers. Spherix Global Insights ...